These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12411927)

  • 21. Retroviral gene therapy--where now?
    Günzburg WH
    Trends Mol Med; 2003 Jul; 9(7):277-8. PubMed ID: 12900211
    [No Abstract]   [Full Text] [Related]  

  • 22. Addendum to the points to consider in human somatic cell and gene therapy (1991).
    Epstein S
    Hum Gene Ther; 1996 Jun; 7(9):1181-90. PubMed ID: 8773519
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
    Couzin J; Kaiser J
    Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene therapy in the clinic: whose risks?
    Ashcroft RE
    Trends Biotechnol; 2004 Nov; 22(11):560-3. PubMed ID: 15491799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy trials face further scrutiny.
    Greener M
    Mol Med Today; 2000 Jun; 6(6):211. PubMed ID: 10840374
    [No Abstract]   [Full Text] [Related]  

  • 26. A voluntary moratorium?
    Verma IM
    Mol Ther; 2003 Feb; 7(2):141. PubMed ID: 12638540
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
    Kaiser J
    Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gene therapy for severe combined immunodeficiency linked to chromosome X].
    Fischer A
    Hematol Cell Ther; 1997 Apr; 39(2):97. PubMed ID: 9229544
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene-therapy trials to restart following cancer risk review.
    Check E
    Nature; 2005 Mar; 434(7030):127. PubMed ID: 15758959
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene therapy for SCID--a complication after remarkable progress.
    Buckley RH
    Lancet; 2002 Oct; 360(9341):1185-6. PubMed ID: 12401240
    [No Abstract]   [Full Text] [Related]  

  • 31. Gene therapy: shining hopes dented - but not dashed.
    Check E
    Nature; 2002 Dec 19-26; 420(6917):735. PubMed ID: 12490910
    [No Abstract]   [Full Text] [Related]  

  • 32. Risks of gene therapy should be weighed against lack of alternatives for many diseases.
    MacLaren RE; Ali RR; Thrasher AJ
    BMJ; 2005 Apr; 330(7494):791. PubMed ID: 15802733
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful gene therapy for severe combined immunodeficiency.
    Rosen FS
    N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
    [No Abstract]   [Full Text] [Related]  

  • 34. Big changes at the RAC!
    Anderson WF
    Hum Gene Ther; 1994 Nov; 5(11):1309-10. PubMed ID: 7893801
    [No Abstract]   [Full Text] [Related]  

  • 35. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; von Kalle C; Schmidt M; Le Deist F; Wulffraat N; McIntyre E; Radford I; Villeval JL; Fraser CC; Cavazzana-Calvo M; Fischer A
    N Engl J Med; 2003 Jan; 348(3):255-6. PubMed ID: 12529469
    [No Abstract]   [Full Text] [Related]  

  • 36. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidance for human somatic cell therapy and gene therapy. March 1998. Center for Biologics Evaluation and Research, Food and Drug Administration.
    Hum Gene Ther; 1998 Jul; 9(10):1513-24. PubMed ID: 9681422
    [No Abstract]   [Full Text] [Related]  

  • 38. Gene therapy setback.
    Beardsley T
    Sci Am; 2000 Feb; 282(2):36-7. PubMed ID: 10710784
    [No Abstract]   [Full Text] [Related]  

  • 39. SCID trials to remain on the 'bubble'.
    Mandavilli A
    Nat Med; 2003 Mar; 9(3):251. PubMed ID: 12612562
    [No Abstract]   [Full Text] [Related]  

  • 40. [Gene therapy and clinical trials].
    Tazawa R; Pradono P; Hagiwara K; Nukiwa T
    Nihon Rinsho; 2002 May; 60 Suppl 5():625-9. PubMed ID: 12101750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.